A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma

Condition(s) studied

Investigational drug(s) / intervention(s)

Glaucoma surgery: This is an implant-free, minimally invasive glaucoma surgery

Study summary

The study will follow a group of patients with glaucoma disease that undergo a surgical procedure intended to reduce the intra-ocular pressure (IOP) for a period of one year.

Eligibility

Primary outcome measure(s)

• Intra Ocular pressure — 12 months
• Use of concomitant topical glaucoma medications — 12 months

Trial sites (1)